[go: up one dir, main page]

ES8705411A1 - Procedimiento para preparar derivados de 1-piperazinacarboxamida - Google Patents

Procedimiento para preparar derivados de 1-piperazinacarboxamida

Info

Publication number
ES8705411A1
ES8705411A1 ES535027A ES535027A ES8705411A1 ES 8705411 A1 ES8705411 A1 ES 8705411A1 ES 535027 A ES535027 A ES 535027A ES 535027 A ES535027 A ES 535027A ES 8705411 A1 ES8705411 A1 ES 8705411A1
Authority
ES
Spain
Prior art keywords
formula
compound
preparation
pharmaceutical compositions
carboxamide derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES535027A
Other languages
English (en)
Other versions
ES535027A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia Animal Health Inc
Original Assignee
Ferrosan AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrosan AB filed Critical Ferrosan AB
Publication of ES535027A0 publication Critical patent/ES535027A0/es
Publication of ES8705411A1 publication Critical patent/ES8705411A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/21—Radicals derived from sulfur analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE 1-PIPERAZINACARBOXAMIDA, DE FORMULA (I) Y DE SUS SALES DE ADICION DE ACIDO FISIOLOGICAMENTE COMPATIBLES. COMPRENDE LA REACCION DE UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA R4-NC-A, PARA OBTENER UN COMPUESTO DE FORMULA (I), EN LAS QUE A Y Z REPRESENTAN OXIGENO O AZUFRE, Y X, Y, R1-R4 PUEDEN SER VARIOS TIPOS DE RADICALES. LA REACCION SE EFECTUA EN UN DISOLVENTE INERTE, EN PRESENCIA DE UNA BASE A UNA TEMPERATURA COMPRENDIDA ENTRE 0JC Y 110JC. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE PSICOSIS Y DEPRESION.
ES535027A 1983-08-10 1984-08-09 Procedimiento para preparar derivados de 1-piperazinacarboxamida Expired ES8705411A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8304361A SE8304361D0 (sv) 1983-08-10 1983-08-10 Novel 1-acylpiperazine derivatives novel 1-acylpiperazine derivatives

Publications (2)

Publication Number Publication Date
ES535027A0 ES535027A0 (es) 1987-05-01
ES8705411A1 true ES8705411A1 (es) 1987-05-01

Family

ID=20352166

Family Applications (3)

Application Number Title Priority Date Filing Date
ES535027A Expired ES8705411A1 (es) 1983-08-10 1984-08-09 Procedimiento para preparar derivados de 1-piperazinacarboxamida
ES552001A Expired ES8704917A1 (es) 1983-08-10 1986-02-14 Procedimiento para prepararar derivados de 1-piperazinacarboximida.
ES556989A Expired ES8802039A1 (es) 1983-08-10 1986-08-01 Procedimiento par preparar derivados de 1-piperazinacarboxamida

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES552001A Expired ES8704917A1 (es) 1983-08-10 1986-02-14 Procedimiento para prepararar derivados de 1-piperazinacarboximida.
ES556989A Expired ES8802039A1 (es) 1983-08-10 1986-08-01 Procedimiento par preparar derivados de 1-piperazinacarboxamida

Country Status (16)

Country Link
US (1) US4935419A (es)
EP (1) EP0136274B1 (es)
JP (1) JPH0723364B2 (es)
AT (1) ATE47850T1 (es)
AU (1) AU569537B2 (es)
CA (1) CA1253148A (es)
DE (1) DE3480395D1 (es)
DK (1) DK157864C (es)
ES (3) ES8705411A1 (es)
FI (1) FI80449C (es)
HU (1) HU196977B (es)
IE (1) IE58065B1 (es)
IL (1) IL72563A (es)
NZ (1) NZ209166A (es)
SE (1) SE8304361D0 (es)
WO (1) WO1985000811A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8500573D0 (sv) * 1985-02-08 1985-02-08 Ferrosan Ab Novel piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain
GB8713240D0 (en) * 1987-06-05 1987-07-08 Proteus Biotech Ltd Hormones
EP0326379B1 (en) * 1988-01-26 1994-06-01 Nippon Chemiphar Co., Ltd. Therapeutic agent for liver disease and piperazine derivatives
US5719156A (en) * 1995-05-02 1998-02-17 Schering Corporation Piperazino derivatives as neurokinin antagonists
US5795894A (en) * 1995-05-02 1998-08-18 Schering Corporation Piperazino derivatives as neurokinn antagonists
US5892039A (en) * 1995-08-31 1999-04-06 Schering Corporation Piperazino derivatives as neurokinin antagonists
US5869488A (en) * 1996-05-01 1999-02-09 Schering Corporation Piperazino derivatives as neurokinin antagonists
US5968929A (en) * 1996-10-30 1999-10-19 Schering Corporation Piperazino derivatives as neurokinin antagonists
EP1158983A4 (en) 1999-03-03 2003-05-21 Merck & Co Inc Prenyl protein transferase inhibitors
US20100093935A1 (en) * 2008-10-15 2010-04-15 Nitto Denko Corporation Method of preparing polyglutamate conjugates
BR112012013305A2 (pt) * 2009-12-16 2016-03-01 Nitto Denko Corp processos para a preparação de ácido poliglutâmico
AU2013245702A1 (en) * 2012-04-14 2014-11-13 Intra-Cellular Therapies, Inc. Organic compounds
PL3838274T3 (pl) 2016-01-26 2024-04-02 Intra-Cellular Therapies, Inc. Pochodna pirydo[3',4':4,5]pirolo[1,2,3-DE]chinoksaliny do zastosowania w leczeniu zaburzeń OUN
WO2018126143A1 (en) 2016-12-29 2018-07-05 Intra-Cellular Therapies, Inc. Organic compounds
WO2018126140A1 (en) 2016-12-29 2018-07-05 Intra-Cellular Therapies, Inc. Organic compounds
WO2019183341A1 (en) 2018-03-23 2019-09-26 Intra-Cellular Therapies, Inc. Organic compounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3000892A (en) * 1959-11-16 1961-09-19 Paul A J Janssen 1-aroylalkyl-4-aroylpiperazines
DE1670431A1 (de) * 1966-03-04 1971-02-11 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung neuer Piperazin-Derivate
GB1143882A (es) * 1966-06-21
GB1186495A (en) * 1968-02-20 1970-04-02 Delalande Sa 0-[3-(4-Fluorobenzoyl) Proplyl]-4-Substituted Piperazines, their Acid Addition Salts and their method of preparation
FR2262521A1 (en) * 1973-08-08 1975-09-26 Delalande Sa 3-(3,4,5-Trimethoxyphenyl)piperazines - with coronary vasodilator, hypotensive, antiinflammatory, analgesic, and antiulcer activity
JPS50131974A (es) * 1974-03-06 1975-10-18
AR207031A1 (es) * 1974-03-06 1976-09-09 Kyorin Seiyaku Kk Procedimiento para preparacion de nuevos derivados de 1-(3-fenilpropil)-4-furoilpiperacina
JPS5143772A (en) * 1974-09-26 1976-04-14 Kyorin Seiyaku Kk 11 * 33 fuenirupuropiru * 44 furoirupiperajinjudotaino seizoho
JPS518283A (en) * 1974-07-09 1976-01-23 Kyorin Seiyaku Kk 11 * 33 fuenirupuropiru * 44 karubamoirupiperajinjudotaino seizoho
JPS5346988A (en) * 1976-10-07 1978-04-27 Kyorin Seiyaku Kk Piperadine derivative
NO154582C (no) * 1978-10-20 1986-11-05 Ferrosan Ab Analogifremgangsmaate for fremstilling av terapeutisk aktive difenyl-dibutylpiperazinkarboksamider.
JPS57500828A (es) * 1980-06-16 1982-05-13
IL67372A (en) * 1981-12-02 1986-04-29 Ferrosan Ab Pharmaceutical compositions comprising 4-(4,4-bis(p-fluorophenyl)butyl)-1-piperazinocarboxylates,certain such novel compounds and their preparation

Also Published As

Publication number Publication date
DE3480395D1 (en) 1989-12-14
AU569537B2 (en) 1988-02-04
NZ209166A (en) 1987-07-31
ES535027A0 (es) 1987-05-01
DK157864C (da) 1990-07-23
EP0136274B1 (en) 1989-11-08
FI851350L (fi) 1985-04-03
JPS60501956A (ja) 1985-11-14
FI80449C (fi) 1990-06-11
DK157485A (da) 1985-04-09
ATE47850T1 (de) 1989-11-15
IL72563A (en) 1988-10-31
SE8304361D0 (sv) 1983-08-10
EP0136274A1 (en) 1985-04-03
JPH0723364B2 (ja) 1995-03-15
DK157485D0 (da) 1985-04-09
US4935419A (en) 1990-06-19
IE58065B1 (en) 1993-06-30
ES8802039A1 (es) 1988-03-16
DK157864B (da) 1990-02-26
FI851350A0 (fi) 1985-04-03
HUT37415A (en) 1985-12-28
WO1985000811A1 (en) 1985-02-28
AU3211184A (en) 1985-03-12
IL72563A0 (en) 1984-11-30
IE842050L (en) 1985-02-10
ES556989A0 (es) 1988-03-16
FI80449B (fi) 1990-02-28
CA1253148A (en) 1989-04-25
HU196977B (en) 1989-02-28
ES8704917A1 (es) 1987-04-16
ES552001A0 (es) 1987-04-16

Similar Documents

Publication Publication Date Title
ES8705411A1 (es) Procedimiento para preparar derivados de 1-piperazinacarboxamida
ES483767A1 (es) Procedimiento para producir n-arilsulfonil-l-argininamidas
ES8603408A1 (es) Un procedimiento para la preparacion de un compuesto de 2-oxindol-1-carboxamida
ES8303421A1 (es) Un procedimiento para la preparacion de 6-alquiliden-penamas.
ES8600263A1 (es) Un compuesto.
YU47010B (sh) Derivati 1,6-naftiridina
ES454085A1 (es) Procedimiento para la preparacion de n-(r-tetrahidrofurfu- ril)-noroximorfona y n-(s-tetrahidrofurfuril)-noroximorfona nuevas.
SE7702130L (sv) Forfarande for framstellning av n-(merkaptoacyl)-histidiner
ES8801639A1 (es) Procedimiento para la obtencion de derivados del acido barbiturico
ES8706644A1 (es) Un procedimiento para preparar derivados de dihidropiridazina
GB1516793A (en) 1,4-dihydropyridine-3,5-dicarboxylic acid diester derivative several processes for its preparation and its use as a coronary therapeutic agent
ES466127A1 (es) Un procedimiento para la preparacion de l-formil-indol-dihi-droindol dimero.
ES435955A1 (es) Un procedimiento para obtener un derivado de pirido (3,4-d) piridezina.
ES468127A1 (es) Un procedimiento para la preparacion de nuevos derivados de pirido (2,1-b) quinazolina
LV5491A3 (lv) 2-tiazolidinona atvasinajumu iegusanas panemiens
JPS51115402A (en) Process for preparation of alpha-amino acid
DK205882A (da) Delta1-pyrrolin-thiolatimethere og fremgangsmaade til deres fremstilling
JPS5279081A (en) Preparation of novel 7-methoxycephalosporins
ES8302686A1 (es) Procedimiento para la obtencion de un nuevo derivado furanico de interes terapeutico.
ES8606273A1 (es) Un procedimiento para la preparacion de compuestos de 2- oxindol
ES8303380A3 (es) "procedimiento para la preparacion del 1,1-dioxidos de 4-hidroxi-2h-1,2-benzotiazina-3-3-carboxamina".
ES8302685A1 (es) Procedimiento para la obtencion de un nuevo derivado de furano terapeuticamente activo.
ES8704151A1 (es) Procedimiento para la preparacion de derivados de n-acil-l- prolina
ES432535A1 (es) Un procedimiento para la preparacion de benzodiazepinas-1,4.
ES8100295A3 (es) Procedimiento para preparar xantinas sustituidas

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20050124